Table 3.
Clinical Outcomes According to Phenotype of Residual Inflammatory Risk
| Overall Population (N = 4,562) | Persistent Low RIR (n = 2,325) | Fortified RIR (n = 468) | Attenuated RIR (n = 934) | Persistent High RIR (n = 835) | P Value | |
|---|---|---|---|---|---|---|
| All-cause death | 238 (5.2) | 71 (3.1) | 34 (7.3) | 47 (5.0) | 86 (10.3) | <0.001 |
| MACE | 522 (11.4) | 217 (9.3) | 66 (14.1) | 115 (12.3) | 124 (14.9) | <0.001 |
| CV death | 92 (2.0) | 28 (1.2) | 15 (3.2) | 17 (1.8) | 32 (3.8) | <0.001 |
| Nonfatal MI | 272 (6.0) | 122 (5.2) | 27 (5.8) | 71 (7.6) | 52 (6.2) | 0.081 |
| Nonfatal stroke | 158 (3.5) | 67 (2.9) | 24 (5.1) | 27 (2.9) | 40 (4.8) | 0.009 |
| Major bleeding | 111 (2.4) | 32 (1.4) | 9 (1.9) | 31 (3.3) | 39 (4.7) | <0.001 |
Values are n (%). Major adverse cardiac events (MACE) included CV death, nonfatal MI, and nonfatal stroke.
Abbreviations as in Table 1.